IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 109 filers reported holding IGM BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,666 | -9.5% | 48,942 | 0.0% | 0.00% | – |
| Q2 2023 | $451,735 | -12.7% | 48,942 | +30.0% | 0.00% | – |
| Q1 2023 | $517,393 | -15.8% | 37,656 | 0.0% | 0.00% | – |
| Q4 2022 | $614,405 | -17.6% | 37,656 | +0.1% | 0.00% | -100.0% |
| Q3 2022 | $746,046 | +7.4% | 37,621 | -0.4% | 0.00% | – |
| Q2 2022 | $694,767 | -14.7% | 37,782 | +20.3% | 0.00% | -100.0% |
| Q1 2022 | $814,434 | +161.0% | 31,418 | +561.6% | 0.00% | – |
| Q3 2021 | $312,000 | -27.8% | 4,749 | -8.6% | 0.00% | – |
| Q2 2021 | $432,000 | +20.0% | 5,197 | +10.6% | 0.00% | – |
| Q1 2021 | $360,000 | -13.9% | 4,698 | -0.7% | 0.00% | – |
| Q4 2020 | $418,000 | +19.8% | 4,730 | +0.1% | 0.00% | – |
| Q3 2020 | $349,000 | +8.7% | 4,726 | 0.0% | 0.00% | – |
| Q2 2020 | $321,000 | +51.4% | 4,726 | +25.2% | 0.00% | – |
| Q1 2020 | $212,000 | – | 3,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |